Ignite Creation Date:
2024-10-25 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06637306
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-09
Brief Title:
Neoadjuvant Dupilumab Pembrolizumab Paclitaxel and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Sponsor:
Organization:
None